Drug Resistance (TB)

Resistance to Rifampin Alone On the Rise

Published in Medical Letter on the CDC and FDA, October 20th, 1997

Monoresistance to rifampin appears to be growing more common, and is often associated with HIV infection, according to a report from the U.S. Centers for Disease Control and Prevention (CDC) and the Los Angeles County Department of Health.

The report was presented by researcher Susan Ashkar and colleagues at the 1997 Infectious Disease Society of America Annual Meeting, held September 13-16 in San Francisco, California.

Mycobacterium tuberculosis with rifampin monoresistance has been uncommon, but now is being seen with increasing frequency.

To elucidate the characteristics of monoresistant TB presentation, Ashkar et al....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1997-10-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry